The Cure Circle
Dr. Smita Karpate, MD
0
The Cure Circle explores regenerative medicine, cell and gene therapy, and the science of true healing. It features conversations with scientists, clinicians, innovators, and thinkers who are reprogramming biology to treat disease. Designed for doctors, researchers, founders, and curious listeners, each episode offers insight into the future of healthcare.
Episodes
-
The Future of Diabetic Foot Care: Wound Healing, Remission & Limb Preservation 28.09.2026 53mWhat does it take to move beyond simply closing a diabetic foot wound and achieve lasting remission? In this episode of The Cure Circle, host Dr. Smita Karpate, MD, speaks with Dr. David G. Armstrong, DPM, PhD, a podiatric surgeon at Keck Medicine of USC and Distinguished Professor of Surgery and Neurological Surgery at the Keck School of Medicine of USC.As a specialist in diabetic foot care, wound remission, and limb preservation, Dr. Armstrong possesses three decades of experience in the field. He brings a clinical and research perspective to one of the most challenging areas of wound care:... -
From Science to Access: Building India’s Cell & Gene Therapy Future 07.09.2026 46mWhat will it take for India to build a cell and gene therapy ecosystem that can compete globally? In Episode 5 of The Cure Circle, host Dr. Smita Karpate, MD, speaks with Dr. Arun Anand, MD, a physician-executive, cell and gene therapy business leader, and nominated expert on the Precision Biotherapeutics Committee, Department of Biotechnology (DBT/BIRAC), Government of India.With more than two decades of experience, Dr. Arun brings a rare blend of clinical expertise, drug development, portfolio and strategy, global and emerging markets, and C-suite operations. As former COO and Board Director... -
Why India Loses Top Scientific Talent 24.08.2026 48mWhat slows cell and gene therapy, biology or systems?In this episode of The Cure Circle, translational immunotherapy researcher Gaurang Telang explains why reproducibility, documentation, and system reliability, not heroics, determine whether CAR-T science reaches patients. A grounded look at what real CGT translation requires.In Episode 4 of The Cure Circle, host Dr. Smita Karpate speaks with Gaurang Telang, a translational T-cell immunotherapy researcher at the Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany, whose work bridges bench-level CAR-T research and GMP-aligned transl... -
CAR-T Therapy in Multiple Myeloma: From Relapse to Real Hope 10.08.2026 37mIn this episode of The Cure Circle, host Dr. Smita Karpate, MD, is joined by Dr. Mallikarjun Kalashetty, DM, Head of Clinical Hematology, Hemato-Oncology, Bone Marrow Transplantation, and Cellular Therapy at Manipal Hospitals, Bengaluru.Multiple myeloma remains one of the most complex and relentless blood cancers, treatable but rarely curable. While modern drug combinations and stem cell transplants have extended survival, relapse is inevitable for most patients. This is where CAR-T therapy is redefining the landscape.Drawing directly from clinical experience at the bedside, Dr. Kalashetty exp... -
Why CMC and Manufacturing Decide CGT Success 27.07.2026 1h 6mIn this episode of The Cure Circle, host Dr. Smita Karpate, MD is joined by Emily Moran, Founder of 3LB Consulting, a global expert at the intersection of cell and gene therapy manufacturing, CMC strategy, and regulatory execution.While cell and gene therapies promise cures once thought impossible, most programs do not fail because of weak science — they fail because execution breaks down. Emily’s work focuses on closing that gap: translating beautiful biology into manufacturable, compliant, and patient-ready therapies.Drawing from nearly two decades in life sciences, vaccines, and advanced th... -
Building Fitter T Cells to Fight Cancer with Prof. Roland Schelker 24.03.2026 1h 6mIn the premiere episode of The Cure Circle, host Dr. Smita Karpate speaks with Prof. Roland Schelker, clinician–scientist at the Leibniz Institute for Immunotherapy, whose work sits at the cutting edge of T-cell engineering, CAR-T therapy, and solid tumor immunotherapy.What began as a routine pharma dinner in 2011 where Prof. Schelker first heard about CTLA-4 checkpoint antibodies became the moment that redirected his scientific career. Today, he is pioneering approaches that go beyond receptor design and focus on something deeper: T-cell fitness and stem-like memory T cells (TSCM) capable of... -
Why The Cure Circle 30.01.2026 2mThe Cure Circle is a global dialogue on regenerative medicine, cell and gene therapy, and the science of true healing. Each episode takes you inside the minds of scientists, clinicians, innovators, and thinkers who are not just treating disease; they’re reprogramming biology itself.Go behind the breakthroughs to discover the personal stories, the collaborations, and the courage driving this new era of medicine. From lab benches to hospital wards, from discovery to delivery, The Cure Circle reveals how healing happens when science and soul finally meet.Inspiring, intelligent, and deeply human,...
Popular in
The podcast also appears in the podcast charts of these countries.